1. 1. Galen Centre for Health and Social Policy, Drug Price Controls In Malaysia: Implications and Considerations, Policy Brief, 2019. https://galencentre.org/2019/07/08/drug-price-controls-in-malaysia-implications-and-considerations-no-5-june-2019/ (accessed Dec. 31, 2022).
2. 2. Mola FL, Sasidharan A, What Drug Price Controls in Malaysia Mean for the Pharmaceutical Industry, Pharm. Ind., vol. XXI, no. 32, pp. 1–6, 2019.
3. 3. Hasan SS, Kow CS, Dawoud D, Mohamed O, Baines D, Babar ZU. Pharmaceutical Policy Reforms to Regulate Drug Prices in the Asia Pacific Region: The Case of Australia, China, India, Malaysia, New Zealand, and South Korea. Value Health Reg Issues. 2019;18:18-23. doi:10.1016/j.vhri.2018.08.007
4. 4. Ministry of Health, Consumer Price Guide (CPG), Ministry of Health, 2018. https://www.pharmacy.gov.my/v2/en/apps/drug-price (accessed Dec. 31, 2022).
5. 5. PhAMA, Medicines price control will have negative repercussions, Pharmaceutical Association of Malaysia, MalaysiaKini, 2019. https://www.malaysiakini.com/letters/494410. (accessed Dec. 31, 2022).